Menopausal hormone therapy (MHT): Refining our understanding of MHT research, optimally applying results, and considering the future of MHT

Journal of Pharmacy Practice

Volumn 25, Issue 3, 2012, Pages 324-330

  Anagnostis, Ellena A ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

estrogen; hormone replacement therapy; menopausal hormone therapy; progestogen

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DROSPERINONE; DROSPIRENONE PLUS ESTRADIOL; ESTRADIOL; ESTRADIOL ACETATE; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRADIOL PLUS NORGESTIMATE; ESTROGEN; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; ORTHOD EST; PLACEBO; PROGESTERONE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; CLINICAL PRACTICE; FOLLOW UP; HEALTH CARE PERSONNEL; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL SOCIETY; MENOPAUSE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; REVIEW; VENOUS THROMBOEMBOLISM;

EID: 84866277649     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190012442064     Document Type: Review

References (33)

1. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health. 1998 ; 19: 55-72 (Pubitemid 28279924)
2. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 ; 75 (6). 1102-1109 (Pubitemid 17081015)
3. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 ; 117 (12). 1016-1037
4. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998 ; 280 (7). 605-613 (Pubitemid 28502636)
5. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 ; 291 (14). 1701-1712 (Pubitemid 38489892)
6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 ; 288 (3). 321-333 (Pubitemid 34761611)
7. Rossouw JE. Postmenopausal hormone therapy for disease prevention: have we learned any lessons from the past?. Clin Pharmacol Ther. 2008 ; 83 (1). 14-16
8. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007 ; 297 (13). 1465-1477 (Pubitemid 46556472)
9. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010 ; 17 (2). 242-255
10. Sturdee DW, Pines A, Archer DF, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2011 ; 14 (3). 302-320
11. Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010 ; 95 (7 suppl 1). s1 - s66
12. Woodis CB. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update. J Pharm Pract. 2010 ; 23 (6). 540-547
13. Shifren JL, Schiff I. Role of hormone therapy in the management of menopause. Obstet Gynecol. 2010 ; 115 (4). 839-855
14. Taylor HS, Manson JE. Update in hormone therapy use in menopause. J Clin Endocrinol Metab. 2011 ; 96 (2). 255-264
15. GuthrieC. The latest on hormone therapy for women. Health 2009. http://www.health.com/health/article/0,20411927,00.html. Accessed June 30, 2011.
16. Raymond J. Safer hormones. Woman's Day. March 2009 ;: 75
17. Graves G October 2010: 152.
18. Chlebowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010 ; 304 (15). 1684-1692
19. Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008 ; 299 (9). 1036-1045 (Pubitemid 351347060)
20. LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011 ; 305 (13). 1305-1314
21. Schenck-Gustafsson K, Brincat M, Erel CT, et al. EMAS position statement: Managing the menopause in the context of coronary heart disease. Maturitas. 2011 ; 68 (1). 94-97
22. Toh S, Hernandez-Diaz S, Logan R, et al. Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med. 2010 ; 152 (4). 211-217
23. Shufelt CL, Johnson BD, Berga SL, et al. Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause. 2011 ; 18 (9). 943-950
24. 2010 position statement of The North American Menopause Society. Menopause. 2010 ; 17 (1). 25-54
25. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006 (4). CD001500
26. Ettinger B, Ensrud KE, Wallace R, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol. 2004 ; 104 (3). 443-451 (Pubitemid 40458828)
27. Inc. NJ: Wayne ; 2007 :
28. Canonico M, Plu-Bureau G, Lowe GD, et al. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ. 2008 ; 336 (7655). 1227-1231 (Pubitemid 351809317)
29. Renoux C, Dell'aniello S, Garbe E, et al. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ. 2010 ; 340: c2519
30. Kronos Early Estrogen Prevention Study (KEEPS). http://clinicaltrials. gov/ct2/show/NCT00154180?term=keeps&rank=14. Accessed June 12, 2011.
31. ELITE: Early versus Late Intervention Trial with Estradiol. http://clinicaltrials.gov/ct2/show/NCT00114517?term=ELITE&intr= hormone&rank=1. Accessed June 12, 2011.
32. North American Menopause Society. http://www.menopause.org/htcharts.pdf. Accessed June 18, 2011.
33. Chen WY, Willett WC, Hankinson SE, et al Chicago, IL: abstract LB-60 ;